NCT07154667

Brief Summary

This study aims to improve surgical outcomes for children and young adults with ear differences severe secondary to congenital conditions (like microtia, a condition where the ear is underdeveloped), trauma (such as dog bites), or surgical resections secondary to skin cancer. The investigators have developed a novel medical device to shape cartilage into pre-determined shapes that, once assembled, assists the surgeon in creating an anatomically accurate cartilaginous ear framework, reduce surgery time, and minimize wire need. Other factors that might affect the quality of surgical outcomes will be examined in clinical trial participants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
57mo left

Started Oct 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Oct 2025Dec 2030

First Submitted

Initial submission to the registry

August 15, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

5.3 years

First QC Date

August 15, 2025

Last Update Submit

December 19, 2025

Conditions

Keywords

microtiaear reconstructioncraniofacial differenceanotiaplastic surgeryear defectear traumaear deficit

Outcome Measures

Primary Outcomes (6)

  • Evaluate the results of patient and parent satisfaction with the constructed ear's shape and appearance and compare the results between the hand-carved cohort and the AuryzoN™ EAR 2.0 cohort using a four-question survey.

    Parents and patients (over age 12) will complete a four-question survey asking how much they like: the shape of the new ear, how the new ear looks, how natural the new ear looks, and the new ear overall. Participants will respond to each question with a rating from 1-5, with 1 being "do not like it at all" and 5 being "like it very much". Investigators will compare the responses from the hand-carved cohort and the AuryzoN™ EAR 2.0 cohort to determine which has more favorable outcomes.

    From the beginning of the study to the end at 5 years

  • Evaluating reduction in operative time between the two techniques.

    Compare changes in operative time between participants enrolled in the AuryzoN™ EAR 2.0 arm and the traditional hand-carving arm.

    From the beginning of the study to the end at 5 years

  • Evaluating reduction in assembly time between the two techniques.

    Compare the assembly time of cartilage into the ear construct between the AuryzoN™ EAR 2.0 arm and the hand-carving technique.

    From the beginning of the study to the end at 5 years

  • Evaluating reduction in wire usage between the two techniques

    Compare the amount of wire required for assembly of the ear construct between the Auryzon™ EAR 2.0 arm and the hand-carving technique.

    From the beginning of the study to the end at 5 years

  • Evaluation of cartilage stability

    Assess cartilage framework stability over 12 months post-surgically using photography, measurements, 3D imaging, and histopathological analysis.

    From the beginning of the study to the end at 5 years

  • Evaluation of resorption rates

    Assess resorption rates over 12 months post-surgically using photography, measurements, 3D imaging and histopathological analysis.

    From the beginning of the study to the end at 5 years

Secondary Outcomes (2)

  • Conduct histopathological analysis assessing outcomes of banked allogeneic cartilage between stage 1 and stage 2 surgeries

    From the beginning of the study to the end at 5 years

  • Assessing any changes to the dimensions of the banked cartilage when it is retrieved for stage 2 reconstruction surgery.

    From the beginning of the study to the end at 5 years

Study Arms (2)

AuryzoN™ EAR 2.0 arm

EXPERIMENTAL

Participants in the AuryzoN™ EAR 2.0 arm will receive ear reconstruction surgery using the AuryzoN™ EAR 2.0 device

Procedure: Use of AuryzoN™ EAR 2.0 device

Hand Carved

ACTIVE COMPARATOR

Participants in this arm will receive ear reconstruction surgery using the hand carved technique

Procedure: Hand carving

Interventions

AuryzoN™ EAR 2.0 is an investigational non-significant risk device developed to improve cartilage construct shape and stability prior to use in ear reconstructive surgery.

AuryzoN™ EAR 2.0 arm
Hand carvingPROCEDURE

Standard hand carving using standard surgical blades will be performed in this intervention arm of the study.

Hand Carved

Eligibility Criteria

Age5 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients aged 5-20 years seeking to undergo surgical ear reconstruction or microtia repair under general anesthesia through NCH-FL
  • Pre-existing physical deformity of the ear necessitating surgical reconstruction
  • Patient of sufficient health to undergo surgery under general anesthesia
  • Sufficient fluency in English or Spanish to complete patient/parent surveys

You may not qualify if:

  • Patients who will be ≤4 years old, or ≥21 years old at time of surgery
  • Patients with ear deformities do not require surgical correction
  • Patient's whose ear reconstruction surgery will be performed somewhere other than Nemours Children's Hospital - Florida
  • Patients determined to be in poor health to undergo surgery under general anesthesia
  • Parental or LAR permission cannot be obtained, and/or patient of sufficient age and cognitive capacity declines to assent
  • Lack of fluency in English or Spanish to complete patient/parent surveys

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Children's Hospital, Florida

Orlando, Florida, 32827, United States

RECRUITING

Related Publications (3)

  • Nagata S. A new method of total reconstruction of the auricle for microtia. Plast Reconstr Surg. 1993 Aug;92(2):187-201. doi: 10.1097/00006534-199308000-00001.

    PMID: 8337267BACKGROUND
  • Tanzer RC. Microtia--a long-term follow-up of 44 reconstructed auricles. Plast Reconstr Surg. 1978 Feb;61(2):161-6. doi: 10.1097/00006534-197802000-00001.

    PMID: 622405BACKGROUND
  • Su-Genyk P, Quatela O, Quatela V. Our Evolution of Approaches to Microtia Reconstruction. Facial Plast Surg Clin North Am. 2024 Feb;32(1):105-125. doi: 10.1016/j.fsc.2023.09.002.

    PMID: 37981407BACKGROUND

Related Links

MeSH Terms

Conditions

Congenital MicrotiaMicrotia-AnotiaEar Deformities, Acquired

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Angelo A Leto Barone, MD

    Nemours Children's Hospital, Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Heaven Sippio - Executive Assistant

CONTACT

Ishpriya Sharma - Research Project Specialist, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Craniofacial and Pediatric Plastic Surgeon

Study Record Dates

First Submitted

August 15, 2025

First Posted

September 4, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

December 29, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations